BMY beats Street EPS

Bristol-Myers (BMY) posted third quarter non-GAAP EPS of $0.44, beating by $0.05 the Street estimate of $0.39,

Read the full 176 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE